company background image
ABDX logo

Abingdon Health AIM:ABDX Stock Report

Last Price

UK£0.077

Market Cap

UK£29.9m

7D

6.9%

1Y

-13.9%

Updated

23 Dec, 2024

Data

Company Financials +

ABDX Stock Overview

Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. More details

ABDX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Abingdon Health Plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Abingdon Health
Historical stock prices
Current Share PriceUK£0.077
52 Week HighUK£0.13
52 Week LowUK£0.065
Beta0.22
1 Month Change6.90%
3 Month Change-16.67%
1 Year Change-13.89%
3 Year Change-75.00%
5 Year Changen/a
Change since IPO-92.65%

Recent News & Updates

Recent updates

Shareholder Returns

ABDXGB Medical EquipmentGB Market
7D6.9%-2.3%-2.2%
1Y-13.9%-10.6%2.4%

Return vs Industry: ABDX underperformed the UK Medical Equipment industry which returned -10.6% over the past year.

Return vs Market: ABDX underperformed the UK Market which returned 2.4% over the past year.

Price Volatility

Is ABDX's price volatile compared to industry and market?
ABDX volatility
ABDX Average Weekly Movement6.4%
Medical Equipment Industry Average Movement6.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: ABDX has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: ABDX's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200884Chris Henry Yateswww.abingdonhealth.com

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Abingdon Health Plc Fundamentals Summary

How do Abingdon Health's earnings and revenue compare to its market cap?
ABDX fundamental statistics
Market capUK£29.85m
Earnings (TTM)-UK£1.27m
Revenue (TTM)UK£6.14m

4.9x

P/S Ratio

-23.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ABDX income statement (TTM)
RevenueUK£6.14m
Cost of RevenueUK£2.46m
Gross ProfitUK£3.68m
Other ExpensesUK£4.95m
Earnings-UK£1.27m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0033
Gross Margin59.97%
Net Profit Margin-20.72%
Debt/Equity Ratio32.1%

How did ABDX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 22:15
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abingdon Health Plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emma UlkerWH Ireland Limited
Emma UlkerZeus Capital Limited